Ranok Therapeutics to Present at BMO Biopharma Spotlight Series on Protein Degraders and Other Next Gen Technologies

5 years ago

--CSO Kevin Foley to highlight FDA IND clearance for Ranok’s first clinical program, RNK05047, that was developed using the company’s…

Expo Bazaar USA — Digital B2B Marketplace for Retailers Seeking Artisanal Home Products From India — To Launch in March 2022

5 years ago

The first-of-its-kind online service connects independent specialty stores and designers with handicrafts, gifts and home décor merchandise from India DALLAS--(BUSINESS…

Japan Gift Card and Incentive Card Market Report 2022: Market is Expected to Grow by 10.7% to Reach $20,188.0 Million in 2022 – Forecast to 2026 – ResearchAndMarkets.com

5 years ago

DUBLIN--(BUSINESS WIRE)--The "Japan Gift Card and Incentive Card Market Intelligence and Future Growth Dynamics (Databook) - Q1 2022 Update" report…

Japan Gift Card and Incentive Card Market Report 2022: Market is Expected to Grow by 10.7% to Reach $20,188.0 Million in 2022 – Forecast to 2026 – ResearchAndMarkets.com

5 years ago

DUBLIN--(BUSINESS WIRE)--The "Japan Gift Card and Incentive Card Market Intelligence and Future Growth Dynamics (Databook) - Q1 2022 Update" report…

Japan Gift Card and Incentive Card Market Report 2022: Market is Expected to Grow by 10.7% to Reach $20,188.0 Million in 2022 – Forecast to 2026 – ResearchAndMarkets.com

5 years ago

DUBLIN--(BUSINESS WIRE)--The "Japan Gift Card and Incentive Card Market Intelligence and Future Growth Dynamics (Databook) - Q1 2022 Update" report…

ValenzaBio and Novelty Nobility Announce Exclusive License Agreement for Potential Best-in-Class Anti-c-KIT Monoclonal Antibody

5 years ago

BETHESDA, Md. & PANGYO, South Korea--(BUSINESS WIRE)--ValenzaBio, Inc., a biopharmaceutical company developing monoclonal antibody (mAb) therapeutics for autoimmune and inflammatory…

ValenzaBio and Novelty Nobility Announce Exclusive License Agreement for Potential Best-in-Class Anti-c-KIT Monoclonal Antibody

5 years ago

BETHESDA, Md. & PANGYO, South Korea--(BUSINESS WIRE)--ValenzaBio, Inc., a biopharmaceutical company developing monoclonal antibody (mAb) therapeutics for autoimmune and inflammatory…

ValenzaBio and Novelty Nobility Announce Exclusive License Agreement for Potential Best-in-Class Anti-c-KIT Monoclonal Antibody

5 years ago

BETHESDA, Md. & PANGYO, South Korea--(BUSINESS WIRE)--ValenzaBio, Inc., a biopharmaceutical company developing monoclonal antibody (mAb) therapeutics for autoimmune and inflammatory…

JCR Pharmaceuticals’ Research Presentations at WORLDSymposium™ 2022 Showcase JR-141 (Pabinafusp Alfa) and Other Investigational Treatments for Lysosomal Storage Disorders

5 years ago

- Presentations Highlight Potential Benefits of Therapies Incorporating J-Brain Cargo®, JCR’s Proprietary, Blood-Brain Barrier-Penetrating Technology - HYOGO, Japan--(BUSINESS WIRE)--JCR Pharmaceuticals…

JCR Pharmaceuticals’ Research Presentations at WORLDSymposium™ 2022 Showcase JR-141 (Pabinafusp Alfa) and Other Investigational Treatments for Lysosomal Storage Disorders

5 years ago

- Presentations Highlight Potential Benefits of Therapies Incorporating J-Brain Cargo®, JCR’s Proprietary, Blood-Brain Barrier-Penetrating Technology - HYOGO, Japan--(BUSINESS WIRE)--JCR Pharmaceuticals…

Show more Posts
Show previous Posts

Search